Treatment continuation and factors associated with discontinuation with 3-month paliperidone palmitate in patients with schizophrenia: a post hoc analysis of post-marketing surveillance data in Japan
IntroductionSchizophrenia requires sustained treatment to prevent relapse and maintain functional stability. Poor adherence to oral antipsychotics is common and increases the risk of relapse and rehospitalization. Long-acting injectable antipsychotics, such as paliperidone palmitate 3-month formulat...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2026-03-01
|
| Serie: | Frontiers in Psychiatry |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fpsyt.2026.1751249/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|